Development of a New Method for Liver Stiffness Measurement Using FibroScan

M148 - Development of a New Method for Liver Stiffness Measurement Using FibroScan

This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 153 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.

Inclusion Criteria:

• Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology department for liver disease, suspected liver disease or consequences of liver disease, all etiologies combined.
• Adult patient able to give his written consent
• Patient affiliated to the French Social Security system

Exclusion Criteria:

• Vulnerable patients
• Patients with liver ascites
• Patients with heart failure